5ARI
DrugExposure to finasteride/dutasteride
NCT Number: NCT02876757
In December 2015, Health Canada issued a warning about a potential relationship between suicide and finasteride use and called for further research. No population based studies have assessed the risk of suicide with finasteride use, and this risk is not currently part of the product monograph. Furthermore, the link between depression and finasteride has not been well studied in the older population who are the primary users of this medication.
Looking for future studies?
Notify Me66 year–120 year
Male
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Exposure to finasteride/dutasteride
Time frame: Through study completition, an average of 18 months.
i. suicide=1, or ii. dx10code1-25= ICD10 X60-84 AND dischdisp="07".
Time frame: Through study completition, an average of 18 months.
i. Self injury attempts: D1A or selfinjury_attempt=3, 4, 5, or 6 ii. Self injury intent: D1B or selfinjury_intent=1 iii. Self injury considered: D1C or selfinjury_cons=3, 4, 5 or 6 iv. Self injury plan: D1DB or suicide_plan=1
Time frame: Through study completition, an average of 18 months.
i. OHIP dxcode: 311 ii. ICD 10: F32.0, F32.1, F32.2, F32.3, F32.8, F32.9, F33.0, F33.1, F33.2, F33.3, F33.4, F33.8, F34.1 iii. Psychiatry visits defined as any of these OHIP fee codes: A195, A895, A190, A795, A695, A395, A196, A193, A194, A191, A192 iv. OMHRS: 29620-29626, 29630-29636, 31100 (major depressive disorder)
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05914519
BPH, Ejaculatory Dysfunction
Sohag, Sohag Governorate, Egypt
View Trial DetailsNCT06351579
BPH, Female Urogenital Diseases
Durham, North Carolina, United States
View Trial DetailsNCT04826887
BPH, Benign Prostatic Hyperplasia
Kansas City, Kansas, United States
View Trial DetailsNCT03912558
BOO - Bladder Outflow Obstruction, BPH
Be’er Ya‘aqov, Israel
View Trial Details